Literature DB >> 35584711

Atrial fibrillation in hypertrophic cardiomyopathy - A contemporary mini-review.

Stylianos Dragasis1, Konstantinos Vlachos2, Ourania Kariki2, Stavroula Koskina2, Andromahi Zygouri2, Ilias G Patsiotis3, Aris Anastasakis2, George Athanasopoulos2, Konstantinos Ritsatos2, Konstantinos Letsas2, Michael Efremidis2.   

Abstract

Hypertrophic cardiomyopathy (HCM) represents the most common genetically inherited cardiovascular disorder and a leading cause of heart failure and sudden cardiac death. Atrial fibrillation (AF) is the most common arrhythmia encountered in HCM patients, primarily due to the process of left atrium dilatation and remodeling. Its presence typically leads to progressive functional decline, increased frequency of heart failure hospitalizations, and increased thromboembolic risk. In this mini-review, we summarize the contemporary data on AF pathophysiology, risk factors, and management in HCM patients suffering from AF.
Copyright © 2022 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arterial thromboembolism; Atrial fibrillation; Hypertrophic cardiomyopathy

Mesh:

Year:  2022        PMID: 35584711     DOI: 10.1016/j.hjc.2022.05.002

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666            Impact factor:   5.795


  2 in total

1.  Effect of Perioperative Comprehensive Nursing Intervention on the Rehabilitation Effect of Radiofrequency Ablation for Patients with Hypertrophic Obstructive Cardiomyopathy.

Authors:  Xiaoping Xiang; Yanru Chen; Lijun Dai
Journal:  Contrast Media Mol Imaging       Date:  2022-08-11       Impact factor: 3.009

2.  Twenty-four hour variability of inverted T-waves in patients with apical hypertrophic cardiomyopathy.

Authors:  Fei Ma; Yating Yang; Jingwen Tao; Xiaoyan Deng; Xufeng Chen; Jingjing Fan; Xuelei Bai; Tongyu Dai; Sheng Li; Xiaoyun Yang; Fan Lin
Journal:  Front Cardiovasc Med       Date:  2022-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.